Anaplastic carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Animal Mammary Neoplasms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Carcinoma
|
0.300 |
Biomarker
|
group |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Carcinoma, Spindle-Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Carcinomatosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Colorectal Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Corpuscular Hemoglobin Concentration Mean
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
Early gastric cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
MS revealed that the ribosomal protein L6 (RPL6) expression was significantly downregulated only in EGC tissues vs. nontumorous tissues; this was validated by western blotting (<i>n</i> = 30, <i>p</i> = 0.0094).
|
31565098 |
2019 |
Gallbladder Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression.
|
31487418 |
2019 |
Influenza A
|
0.010 |
Biomarker
|
disease |
BEFREE |
We show that 60S ribosomal proteins L6 (RPL6) and RPL28, which are adjacent on the ribosome, play opposite roles in generating an influenza A virus-encoded peptide.
|
30712990 |
2019 |
Malignant neoplasm of gallbladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression.
|
31487418 |
2019 |
Malignant neoplasm of stomach
|
0.020 |
Biomarker
|
disease |
BEFREE |
The present study was designed to investigate the potential role of RPL6 in therapy of gastric cancer for clinic.
|
22043320 |
2011 |
Malignant neoplasm of stomach
|
0.020 |
Biomarker
|
disease |
BEFREE |
Bioinformatics analysis predicted that there is a hsa_circ_0006848/hsa_miR-329-5p/RPL6 axis in GC progression.
|
31565098 |
2019 |
Mammary Carcinoma, Animal
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Mammary Neoplasms, Experimental
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Noonan Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
RPL6 was mapped to chromosome 12q24.1 between the markers D12S84 and D12S861, which is in the critical region for Noonan syndrome.
|
11043511 |
2000 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
|
18353766 |
2008 |
Paroxysmal nocturnal hemoglobinuria
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In contrast, significant upregulation of TAXREB107 is present only in some of our PNH patients.
|
11823033 |
2002 |
Penis carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The RaSH approach identified differential expression of Annexin A1 (ANXA1), p16, RPL6, PBEF1 and KIAA1033 in high-risk HPV positive penile carcinoma; ANXA1 and p16 were overexpressed in penile squamous cells positive for high-risk HPVs compared to normal penile samples by qPCR.
|
23341933 |
2013 |
Stage 0 Gallbladder Cancer AJCC v8
|
0.010 |
Biomarker
|
disease |
BEFREE |
Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression.
|
31487418 |
2019 |
Stage IIA Gallbladder Cancer AJCC v8
|
0.010 |
Biomarker
|
disease |
BEFREE |
Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression.
|
31487418 |
2019 |
Stage IIB Gallbladder Cancer AJCC v8
|
0.010 |
Biomarker
|
disease |
BEFREE |
Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression.
|
31487418 |
2019 |
Stage III Gallbladder Cancer AJCC v8
|
0.010 |
Biomarker
|
disease |
BEFREE |
Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression.
|
31487418 |
2019 |
Stage IV Gallbladder Cancer AJCC v8
|
0.010 |
Biomarker
|
disease |
BEFREE |
Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression.
|
31487418 |
2019 |
Stomach Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Bioinformatics analysis predicted that there is a hsa_circ_0006848/hsa_miR-329-5p/RPL6 axis in GC progression.
|
31565098 |
2019 |